CAR-T Cell Immunotherapy for HCC Targeting GPC3

Summary

The purpose of this study is to preliminarily evaluate the safety and efficacy of CAR-T cell immunotherapy for GPC3 positive hepatocellular carcinoma.

Timeline

Start

2015-06

Primary completion

2016-08-15

Completion

2016-08-15

Outcome

Outcome not reported

Stopped: “Project terminated due to revision of local regulations”

Drugs

Indications